CaMKI δ Antibodies

Santa Cruz Biotechnology provides a broad selection of CaMKI δ monoclonal antibodies for research focused on understanding calcium/calmodulin-dependent protein kinase I delta (CaMKI δ). CaMKI δ monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CaMKI δ plays a crucial role in cellular signaling pathways, particularly in response to calcium fluctuations. CaMKI δ actively participates in muscle contraction, neurotransmitter release, and gene expression regulation. Research has shown CaMKI δ to be particularly significant in cardiovascular and neurological studies. Scientists worldwide rely on CaMKI δ monoclonal antibodies to advance their understanding of cellular processes and signaling mechanisms. Ongoing studies of CaMKI δ continue to reveal new insights into its role in both normal physiology and disease states. The high specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge and potential therapeutic developments.